What is In2Great?
In2Great operates as a specialized functional medicine clinic based in Kansas City, distinguishing itself through a rigorous, evidence-based methodology that prioritizes the identification of underlying health drivers over symptomatic management. By integrating over 15 distinct therapeutic modalities—including SOT Therapy, EBOO Therapy, and advanced IV Nutrition—the clinic provides a highly personalized care architecture for patients navigating complex chronic conditions and metabolic dysfunctions. With a legacy spanning two decades, the company has established a robust clinical framework that bridges the gap between traditional diagnostics and holistic wellness, catering to a growing demographic of patients seeking comprehensive, long-term health solutions.
How much funding has In2Great raised?
In2Great has raised a total of $59K across 1 funding round:
Debt
$59K
Debt (2021): $59K with participation from PPP
Key Investors in In2Great
PPP
Public-Private Partnership
What's next for In2Great?
The infusion of capital is expected to catalyze a multi-faceted growth strategy, focusing on the expansion of clinical infrastructure and the enhancement of its proprietary integrative therapy suite. As the company transitions through its current growth phase, leadership is likely to prioritize the scaling of its patient-centric care model to address the rising demand for personalized metabolic health interventions. By leveraging this financial backing, In2Great is poised to solidify its market position, potentially exploring new geographic territories or investing in advanced diagnostic technologies to further refine its patient outcomes and operational efficiency in the competitive landscape of functional medicine.
See full In2Great company page
